Claims
- 1. A method of functionalizing a solid support comprising contacting said support with a bromoacetamidosilane of Formula I
- 2. The method according to claim 1 wherein
R is a linear or branched C1-C10 alkyl, R1 is a C1-C10 linear or branched alkyl and R2 is a C1-C10 linear or branched alkyl, a C1C10 linear or branched alkoxy or phenoxy, and X is (CH2)n wherein n is 0 to 25.
- 3. The method according to claim 1 wherein said bromoacetamidosilane is N-(3-dimethylethoxysilylpropyl) bromoacetamide.
- 4. The method according to claim 1 wherein said solid support is a glass support.
- 5. A functionalized solid support produced according to the method of claim 1.
- 6. The functionalized support according to claim 5 wherein said functionalized support is a functionalized glass support.
- 7. A compound of the Formula I
- 8. The compund of claim 7 wherein
R is a linear or branched C1-C10 alkyl, R1 is a C1-C10 linear or branched alkyl and R2 is a C1-C10 linear or branched alkyl, a C1-C10 linear or branched alkoxy or phenoxy, and X is (CH2)n wherein n is 0 to 25.
- 9. A solid support silanized with a bromoacetamidosilane of Formula I:
- 10. The support according to claim 9 wherein said support is a glass support.
- 11. A method of immobilizing a phosphorothioate-terminated biopolymer on the support according to claim 9 comprising contacting said biopolymer with said support under conditions such that a bromoacetamide group present on said support reacts with said phosphorothioate.
- 12. The method according to claim 11 wherein said support is a glass support.
- 13. The method according to claim 11 wherein said biopolymer is a 5′ phosphorothioate oligonucleotide.
- 14. A composition comprising a phosphorothioate-terminated biopolymer and a bromoacetamidosilylated solid support wherein said phosphorothioate-terminated biopolymer is bound to said support via a bromoacetamide group.
- 15. The composition according to claim 14 wherein said biopolymer is a 5′ phosphorothioate oligonucleotide.
- 16. The composition according to claim 14 wherein said support is glass.
- 17. The composition according to claim 14 wherein said biopolymer bears a detectable label.
- 18. The composition according to claim 17 wherein said biopolymer is fluoresceinated.
- 19. A kit comprising the support according to claim 9 disposed within a container means.
- 20. A kit comprising the composition according to claim 14 disposed within a container means.
Parent Case Info
[0001] This application claims priority from Provisional Application No. 60/208,493, filed Jun. 2, 2000, the entire contents of which are incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60208493 |
Jun 2000 |
US |